JPRN-UMIN000022624已完成未知
Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHD - Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with a history of shock or hypersensitivity to this drug. 2.Patients who are complicated by infectious diseases. 3.Patients with a history of myocardial infarction or unstable angina. 4.Patients with reduced severe bone marrow function. 5.Women who may be pregnant or pregnant. 6.Lactating women
研究者
相似试验
已完成
不适用
Tocilizumab long-term extension trial in patients with adult onset stillAdult onset still diseaseJPRN-UMIN000018414Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine34
招募中
3 期
Tocilizumab in severe COVID-19COVID-19.COVID-19U07.1IRCT20150303021315N17Aryogen Pharmed85
已完成
不适用
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000020389Kanazawa University Hospital, Department of dermatology5
已完成
4 期
A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency.Rheumatoid arthritisJPRN-UMIN000014934HO Kumamoto Saishunsou National Hospital400
已完成
4 期
ong term prospective follow-up study of tocilizumab (RoActermraR) administered to patients with rheumatoid arthritis in daily clinical practice.inflammatory disease1000381610023213NL-OMON34333Jan van Breemen Instituut200